Mersana Therapeutics, Inc. (MRSN)
Q1 2020 Earnings Conference Call
May 8, 2020 08:00 AM ET
Company Participants
Sarah Carmody – Executive Director-Investor Relations and Corporate Communications
Anna Protopapas – President and Chief Executive Officer
Dirk Huebner – Chief Medical Officer
Tim Lowinger – Chief Science and Technology Officer
Brian DeSchuytner – Senior Vice President-Finance and Product Strategy
Eva Jack – Chief Business Officer
Conference Call Participants
Jonathan Chang – SVB Leerink
Earl DeSouza – H.C. Wainwright
Boris Peaker – Cowen
Tom Shrader – BTIG
Jessica Fye – J.P. Morgan
Mike Ulz – Baird
David Nierengarten